Research into the prescribing of approved new medicines across Scotland is showing access can depend on where you live – with the differences being most stark for dual-use medicines for diabetes and weight management. The Scottish government says its planned reform of NHS Scotland should improve equality of access. The Association of the British Pharmaceutical Industry (ABPI), a trade body for companies developing, manufacturing read more…